Ullmer C

Title : Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity - Soethoudt_2017_Nat.Commun_8_13958

Author(s) : Soethoudt M , Grether U , Fingerle J , Grim TW , Fezza F , De Petrocellis L , Ullmer C , Rothenhausler B , Perret C , van Gils N , Finlay D , MacDonald C , Chicca A , Gens MD , Stuart J , de Vries H , Mastrangelo N , Xia L , Alachouzos G , Baggelaar MP , Martella A , Mock ED , Deng H , Heitman LH , Connor M , Di Marzo V , Gertsch J , Lichtman AH , Maccarrone M , Pacher P , Glass M , van der Stelt M

Ref : Nat Commun , 8 :13958 , 2017

PubMedID: 28045021

Title : Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors - Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024

Author(s) : Samochocki M , Hoffle A , Fehrenbacher A , Jostock R , Ludwig J , Christner C , Radina M , Zerlin M , Ullmer C , Pereira EF , Lubbert H , Albuquerque EX , Maelicke A

Ref : Journal of Pharmacology & Experimental Therapeutics , 305 :1024 , 2003

PubMedID: 12649296

Ullmer C

References (2)

1. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity - Soethoudt_2017_Nat.Commun_8_13958

2. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors - Samochocki_2003_J.Pharmacol.Exp.Ther_305_1024